These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4978385)

  • 21. Serum free thyroxine and binding-proteins after muscular exercise.
    De Nayer P; Malvaux P; Ostyn M; Van den Schrieck HG; Beckers C; De Visscher M
    J Clin Endocrinol Metab; 1968 May; 28(5):714-6. PubMed ID: 4968189
    [No Abstract]   [Full Text] [Related]  

  • 22. Raided free thyroxine values in patients with familial elevation of thyroxine binding globulin.
    Thomson JA; Meredith EM; Baird SG; McAinsh WR; Hutchison JH
    Q J Med; 1971 Oct; 40(160):577. PubMed ID: 4110161
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth and liver glycerophosphate dehydrogenase response to thyroxine and p-chlorophenoxyisobutyrate.
    Richert DA; Westerfeld WW
    Endocrinology; 1970 Dec; 87(6):1274-81. PubMed ID: 5529883
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of atromid S on certain fractions of collagen from the aortic wall of rats being on atherogenic diet].
    Hanzlik J; Lopatyński J; Tyburczyk W
    Pol Tyg Lek; 1967 Jan; 22(2):48-50. PubMed ID: 6040630
    [No Abstract]   [Full Text] [Related]  

  • 25. Inherited abnormality of thyroxine-binding globulin with no demonstrable thyroxine-binding activity and high serum levels of denatured thyroxine-binding globulin.
    Murata Y; Takamatsu J; Refetoff S
    N Engl J Med; 1986 Mar; 314(11):694-9. PubMed ID: 3081807
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modes and levels of action of clofibrate].
    Thorp JM
    Rev Atheroscler (Paris); 1966; 8(1):2-11. PubMed ID: 5960552
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of chlorphenisate on serum lipids].
    Cisternas H; Arteaga A; Allende ME
    Rev Med Chil; 1968 Nov; 96(11):723-8. PubMed ID: 5714889
    [No Abstract]   [Full Text] [Related]  

  • 28. Thyroxine binding proteins, free thyroxine and thyroxine turnover interrelationships during acute infectious illness in man.
    Lutz JH; Gregerman RI; Spaulding SW; Hornick RB; Dawkins AT
    J Clin Endocrinol Metab; 1972 Aug; 35(2):230-49. PubMed ID: 4627324
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of variations of thyroxine-binding globulin capacity on the disappearance of triiodothyronine from the plasma.
    Zaninovich AA; Volpe R; Ezrin C
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1601-7. PubMed ID: 4981512
    [No Abstract]   [Full Text] [Related]  

  • 30. Thyroxine-protein interactions. VII. Effect of thyroxine analogs on the binding of 125-I-thyroxine to highly purified human thyroxine-binding globulin.
    Hao YL; Tabachnick M
    Endocrinology; 1971 Jan; 88(1):81-92. PubMed ID: 4991825
    [No Abstract]   [Full Text] [Related]  

  • 31. Decreased serum free thyroxine concentration in patients treated with diphenylhydantoin.
    Chin W; Schussler GC
    J Clin Endocrinol Metab; 1968 Feb; 28(2):181-6. PubMed ID: 4965869
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyroxine binding to serum proteins in children and adolescents.
    Riecanský I
    Endokrinologie; 1967; 52(3):228-31. PubMed ID: 4968557
    [No Abstract]   [Full Text] [Related]  

  • 33. [Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)].
    Araki Y; Amagase H
    Fukuoka Igaku Zasshi; 1974 Jul; 65(7):465-72. PubMed ID: 4474120
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of clofibrate on serum and hepatic lipids in nephrotic rats.
    Hoak JC; Connor WE; Armstrong ML; Warner ED
    Lab Invest; 1968 Oct; 19(4):370-5. PubMed ID: 5699117
    [No Abstract]   [Full Text] [Related]  

  • 35. THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH; STRISOWER B
    J Clin Endocrinol Metab; 1964 Feb; 24():139-44. PubMed ID: 14123837
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of CPIB ester on plasma free fatty acid levels in man.
    Rifkind BM
    Metabolism; 1966 Aug; 15(8):673-5. PubMed ID: 5341113
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrinolytic activity and reduction of platelet adhesiveness following prolonged administration of ethyl-chlorophenoxy-isobutyrate (Atromid-S).
    Gibelli A; Frandoli G; Giarola P; De Nicola P
    Hemostase; 1966 Oct; 6(4):285-6. PubMed ID: 5986050
    [No Abstract]   [Full Text] [Related]  

  • 38. Hereditary abnormalities of thyroxine-binding globulin concentration. A study of 19 kindreds with inherited increase or decrease of thyroxine-binding globulin.
    Burr WA; Ramsden DB; Hoffenberg R
    Q J Med; 1980; 49(195):295-313. PubMed ID: 6162169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 40. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
    Oliver MF
    Bull N Y Acad Med; 1968 Aug; 44(8):1021-7. PubMed ID: 4875747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.